Sandra Heskamp

Sandra Heskamp studied Biomedical Sciences at the Radboud University of Nijmegen. In 2009, she graduated in two master’s: Epidemiology and Biostatistics and Human Pathobiology. That same year she started her PhD project Molecular Imaging of Receptor Tyrosine Kinases in Cancer, a collaborative project between the department of Nuclear Medicine and Medical Oncology. During her PhD she also worked as a visiting researcher at the Technical University Munich to study the potential of alpha-emitting radionuclides for cancer treatment. In June 2014, she obtained her PhD and started working as a post-doc at the department of Medical Imaging at the Radboudumc. In 2021 she was appointed as full professor and currently she leads a research group focusing on nuclear imaging and therapy in immuno-oncology.

Sandra received several personal grants and awards, including a Veni and Vidi, and she is principal investigator of several collaborative grants. She is president of the Dutch Society of Clinical Radiochemistry (NKRV), co-chair of the Oncoimmunology & Therapy group of the European Society of Molecular Imaging (ESMI), board member of Dutch journal for Nuclear Medicine (TvNG) and chair of the Radboudumc Technology Center Imaging.